Analyses of data from clinical practice also show the presence of racial and social-economic status disparities in the initiation of innovative treatments, including GLP-1RAs
Available from: Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders
Ozempic face is a term used to describe the hollow, gaunt, or prematurely aged appearance that some people develop during or after rapid weight loss from GLP-1 weight-loss medications like Ozempic
2009 , 19(5) , 399-404 (DOI: 10.1097/JSM.0b013e3181b8b52f)
In the CY 2026 PFS proposed rule (90 FR 32792), we did not propose to revise our burden estimates because the measure suppression policy does not impact reporting requirements of the MIPS Promoting Interoperability performance category and the Medicare Promoting Interoperability Program